Company · CIK 0001273636 · SIC 2836 — Biological Products, (No Diagnostic Substances)
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2019 AFForm 4 → | Mar 13, 5:16 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,667 | $3.97 | $2,648 | 50,620 | — | plan? |
| Feb 11, 2019 AFForm 4 → | Feb 13, 6:30 pm EST | Matthew FeinsodInterim Chief Medical Officer | 2,791 | $3.29 | $2,602 | 49,287 | — | plan? |
| Jan 11, 2019 AFForm 4 → | Jan 15, 7:58 pm EST | Matthew FeinsodInterim Chief Medical Officer | 2,713 | $3.20 | $2,282 | 48,078 | — | plan? |
| Dec 14, 2018 PForm 4 → | Dec 18, 8:29 pm EST | James RosenDirector | 1,000 | $3.38 | $3,381 | 1,000 | — | plan? |
| Dec 14, 2018 PForm 4 → | Dec 18, 8:20 pm EST | William AliskiDirector | 6,000 | $3.25 | $19,477 | 8,500 | +240% | plan? |
| Dec 14, 2018 PForm 4 → | Dec 18, 8:10 pm EST | William A. SullivanChief Financial Officer | 3,000 | $3.33 | $9,990 | 3,000 | — | plan? |
| Dec 14, 2018 SForm 4 → | Dec 18, 7:58 pm EST | Mark S ShearmanChief Scientific Officer | 3,000 | $3.35 | $10,053 | 0 | −100% | plan? |
| Dec 14, 2018 PForm 4 → | Dec 18, 7:36 pm EST | Susan B. WasherPresident and CEO, Director | 2,380 | $3.34 | $7,949 | 22,708 | +11.7% | plan? |
| Dec 11, 2018 AFForm 4 → | Dec 13, 9:23 pm EST | Matthew FeinsodInterim Chief Medical Officer | 2,611 | $6.11 | $3,733 | 46,791 | — | plan? |
| Nov 12, 2018 AFForm 4 → | Nov 14, 4:43 pm EST | Matthew FeinsodInterim Chief Medical Officer | 2,685 | $7.05 | $4,829 | 45,402 | — | plan? |
| Oct 11, 2018 AFForm 4 → | Oct 15, 7:01 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,612 | $6.46 | $3,954 | 44,087 | — | plan? |
| Sep 11, 2018 AFForm 4 → | Sep 13, 5:04 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,685 | $3.93 | $2,689 | 42,699 | — | plan? |
| Aug 13, 2018 AFForm 4 → | Aug 15, 7:07 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,592 | $4.00 | $2,368 | 41,384 | — | plan? |
| Jul 11, 2018 AFForm 4 → | Jul 13, 5:57 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,685 | $4.15 | $2,843 | 39,976 | — | plan? |
| Jun 11, 2018 AFForm 4 → | Jun 13, 7:33 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,606 | $4.55 | $2,757 | 38,661 | — | plan? |
| May 24, 2018 JForm 4 → | May 29, 6:57 pm EDT | Edward HurwitzDirector | 25,672 | — | — | 27,472 | — | plan? |
| May 16, 2018 FForm 4 → | May 18, 6:17 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 3,425 | $5.60 | $19,180 | 37,267 | — | plan? |
| May 11, 2018 AFForm 4 → | May 15, 4:34 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,685 | $4.90 | $3,357 | 40,692 | — | plan? |
| Apr 11, 2018 AFForm 4 → | Apr 13, 4:20 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,685 | $4.00 | $2,740 | 39,377 | — | plan? |
| Mar 28, 2018 AForm 4 → | Mar 30, 6:06 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 10,000 | — | — | 42,126 | — | plan? |
| Mar 12, 2018 AFForm 4 → | Mar 14, 7:49 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,667 | $4.30 | $2,868 | 32,126 | — | plan? |
| Feb 11, 2018 AForm 4 → | Feb 13, 7:06 pm EST | Matthew FeinsodInterim Chief Medical Officer | 2,000 | — | — | 30,793 | — | plan? |
| Feb 9, 2018 AFForm 4/A → | Apr 6, 8:45 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,733 | $3.95 | $2,895 | 26,729 | — | plan? |
| Jan 11, 2018 AFForm 4/A → | Apr 6, 8:26 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 2,791 | $4.30 | $3,401 | 25,462 | — | plan? |
| Jan 11, 2018 AFForm 4 → | Jan 16, 8:29 pm EST | Matthew FeinsodInterim Chief Medical Officer | 2,855 | $4.30 | $3,677 | 28,793 | — | plan? amended |
| Dec 11, 2017 FForm 4 → | Apr 6, 2018, 8:15 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 3,395 | $3.75 | $12,731 | 24,253 | — | plan? late |
| Sep 14, 2017 AForm 4 → | Sep 15, 5:07 pm EDT | Matthew FeinsodInterim Chief Medical Officer | 10,000 | — | — | 27,648 | — | plan? |
| Apr 24, 2017 XForm 4 → | Apr 26, 1:07 pm EDT | Arnold L OronskyDirector | 3,688 | — | — | 11,208 | — | plan? |
| Nov 16, 2016 PForm 4 → | Nov 17, 4:53 pm EST | Ivana MagovcevicDirector | 3,000 | $9.63 | $28,875 | 3,000 | — | plan? |
| Nov 1, 2016 SForm 4 → | Nov 2, 6:42 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 1,000 | $7.05 | $7,052 | 20,400 | −4.67% | plan? |
| Oct 19, 2016 MForm 4/A → | Oct 27, 8:24 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 10,000 | $0.35 | $3,500 | 21,400 | — | plan? |
| Sep 22, 2016 PForm 4 → | Sep 26, 5:20 pm EDT | Mark S ShearmanChief Scientific Officer | 3,000 | $8.87 | $26,602 | 3,000 | — | plan? |
| Sep 19, 2016 PForm 4 → | Sep 20, 4:51 pm EDT | Lawrence E BullockChief Financial Officer | 10,000 | $8.75 | $87,500 | 10,000 | — | plan? |
| Sep 16, 2016 PForm 4 → | Sep 27, 5:12 pm EDT | Stephen W PotterSee Remarks | 1,400 | $8.89 | $12,446 | 1,400 | — | plan? late |
| Aug 29, 2016 MForm 4 → | Aug 30, 5:43 pm EDT | Susan B. WasherSee Remarks, Director | 5,328 | $3.50 | $18,648 | 20,328 | — | plan? |
| Aug 22, 2016 GMForm 4 → | Oct 21, 6:03 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 1,500 | $0.35 | $350 | 12,400 | — | plan? late amended |
| May 25, 2016 MForm 4 → | May 26, 7:03 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 2,000 | $3.50 | $7,000 | 11,900 | — | plan? |
| May 11, 2016 MForm 4 → | May 26, 7:00 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 4,000 | $3.50 | $14,000 | 9,900 | — | plan? late |
| Dec 16, 2015 GForm 5 → | Aug 15, 2016, 5:13 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 1,377 | — | — | 11,900 | — | plan? |
| Feb 23, 2015 SForm 4 → | Feb 24, 4:05 pm EST | GLAXOSMITHKLINE PLCOther | 503,150 | $22.00 | $11,069,602 | 1,436,448 | −25.9% | plan? |
| Jan 23, 2015 SForm 4 → | Jan 26, 6:04 pm EST | Daniel L MenichellaV.P. & Chief Business Officer | 1,996 | $24.90 | $49,700 | 0 | −100% | plan? |
| Jan 23, 2015 MForm 4 → | Jan 26, 6:04 pm EST | Daniel L MenichellaV.P. & Chief Business Officer | 1,996 | $4.90 | $9,780 | 1,996 | — | plan? |
| Dec 10, 2014 SForm 4 → | Feb 12, 2015, 6:31 pm EST | GLAXOSMITHKLINE PLC10% Owner | 50,000 | $21.14 | $1,057,225 | 1,939,598 | −2.51% | plan? late |
| Nov 13, 2014 MForm 5 → | Aug 14, 2015, 4:05 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 7,277 | $1.34 | $9,720 | 7,277 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 AForm 4 → | Nov 19, 8:09 pm EST | Anne VanlentDirector | 10,000 | — | — | 10,000 | — | |
| Nov 15, 2018 AForm 4 → | Nov 19, 7:59 pm EST | James RosenDirector | 10,000 | — | — | 10,000 | — | |
| Nov 15, 2018 AForm 4 → | Nov 19, 7:49 pm EST | Ivana MagovcevicDirector | 10,000 | — | — | 10,000 | — | |
| Nov 15, 2018 AForm 4 → | Nov 19, 7:33 pm EST | Edward HurwitzDirector | 10,000 | — | — | 10,000 | — | |
| Nov 15, 2018 AForm 4 → | Nov 19, 7:26 pm EST | William AliskiDirector | 10,000 | — | — | 10,000 | — | |
| Nov 15, 2018 AForm 4 → | Nov 19, 7:18 pm EST | Scott KoenigDirector | 10,000 | — | — | 10,000 | — | |
| Sep 20, 2018 AForm 4 → | Sep 24, 9:46 pm EDT | William AliskiDirector | 25,000 | — | — | 25,000 | — | |
| Jul 25, 2018 AForm 4/A → | Jul 30, 9:44 pm EDT | Anne VanlentDirector | 10,000 | — | — | 10,000 | — | |
| Jul 25, 2018 AForm 4/A → | Jul 30, 9:39 pm EDT | James RosenDirector | 10,000 | — | — | 10,000 | — | |
| Jul 25, 2018 AForm 4/A → | Jul 30, 9:31 pm EDT | Ivana MagovcevicDirector | 10,000 | — | — | 10,000 | — | |
| Jul 25, 2018 AForm 4/A → | Jul 30, 9:25 pm EDT | Edward HurwitzDirector | 10,000 | — | — | 10,000 | — | |
| Jul 25, 2018 AForm 4/A → | Jul 30, 9:15 pm EDT | Scott KoenigDirector | 10,000 | — | — | 10,000 | — | |
| Jul 25, 2018 AForm 4 → | Jul 27, 6:04 pm EDT | Anne VanlentDirector | 8,000 | — | — | 8,000 | — | amended |
| Jul 25, 2018 AForm 4 → | Jul 27, 5:57 pm EDT | James RosenDirector | 8,000 | — | — | 8,000 | — | amended |
| Jul 25, 2018 AForm 4 → | Jul 27, 5:51 pm EDT | Ivana MagovcevicDirector | 8,000 | — | — | 8,000 | — | amended |
| Jul 25, 2018 AForm 4 → | Jul 27, 5:43 pm EDT | Edward HurwitzDirector | 8,000 | — | — | 8,000 | — | amended |
| Jul 25, 2018 AForm 4 → | Jul 27, 5:37 pm EDT | Scott KoenigDirector | 8,000 | — | — | 8,000 | — | amended |
| Jul 25, 2018 AForm 4 → | Jul 27, 5:27 pm EDT | Stephen W PotterVP and Chief Business Officer | 85,000 | — | — | 85,000 | — | |
| Jul 25, 2018 AForm 4 → | Jul 27, 5:17 pm EDT | William A. SullivanChief Financial Officer | 60,000 | — | — | 60,000 | — | |
| Jul 25, 2018 AForm 4 → | Jul 27, 5:05 pm EDT | Mark S ShearmanChief Scientific Officer | 85,000 | — | — | 85,000 | — | |
| Jul 25, 2018 AForm 4 → | Jul 27, 4:57 pm EDT | Susan B. WasherPresident and CEO, Director | 100,000 | — | — | 100,000 | — | |
| Aug 7, 2017 AForm 4 → | Aug 9, 9:49 pm EDT | William A. SullivanChief Financial Officer | 135,000 | — | — | 135,000 | — | |
| Aug 3, 2017 AForm 4 → | Aug 9, 9:54 pm EDT | Lawrence E BullockChief Financial Officer | 4,168 | — | — | 4,168 | — | late |
| Aug 1, 2017 AForm 4 → | Aug 3, 6:18 pm EDT | Andrew D. AsheGeneral Counsel | 100,000 | — | — | 100,000 | — | |
| Jul 17, 2017 AForm 4 → | Jul 18, 8:40 pm EDT | Mark S ShearmanChief Scientific Officer | 50,000 | — | — | 50,000 | — | |
| Jul 17, 2017 AForm 4 → | Jul 18, 8:39 pm EDT | Michael H. GoldsteinChief Medical Officer | 25,000 | — | — | 25,000 | — | |
| Jul 17, 2017 AForm 4 → | Jul 18, 8:37 pm EDT | Susan B. WasherPresident and CEO, Director | 100,000 | — | — | 100,000 | — | |
| Jul 17, 2017 AForm 4 → | Jul 18, 8:37 pm EDT | Stephen W PotterSee Remarks | 50,000 | — | — | 50,000 | — | |
| Apr 24, 2017 XForm 4 → | Apr 26, 1:07 pm EDT | Arnold L OronskyDirector | 11,895 | — | — | 0 | — | |
| Feb 28, 2017 AForm 4 → | Mar 2, 7:25 pm EST | Arnold L OronskyDirector | 8,000 | — | — | 8,000 | — | |
| Feb 28, 2017 AForm 4 → | Mar 2, 7:23 pm EST | Edward HurwitzDirector | 8,000 | — | — | 8,000 | — | |
| Feb 28, 2017 AForm 4 → | Mar 2, 7:22 pm EST | James RosenDirector | 8,000 | — | — | 8,000 | — | |
| Feb 28, 2017 AForm 4 → | Mar 2, 7:21 pm EST | Anne VanlentDirector | 8,000 | — | — | 8,000 | — | |
| Feb 28, 2017 AForm 4 → | Mar 2, 7:20 pm EST | Ivana MagovcevicDirector | 8,000 | — | — | 8,000 | — | |
| Feb 28, 2017 AForm 4 → | Mar 2, 7:19 pm EST | Scott KoenigDirector | 8,000 | — | — | 8,000 | — | |
| Dec 1, 2016 AForm 4 → | Dec 2, 6:38 pm EST | Michael H. GoldsteinChief Medical Officer | 180,000 | — | — | 180,000 | — | |
| Oct 19, 2016 MForm 4/A → | Oct 27, 8:24 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 10,000 | — | — | 20,511 | — | |
| Oct 19, 2016 MForm 4 → | Oct 21, 6:03 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 1,000 | — | — | 29,511 | — | amended |
| Aug 29, 2016 MForm 4 → | Aug 30, 5:43 pm EDT | Susan B. WasherSee Remarks, Director | 5,328 | — | — | 0 | — | |
| Aug 17, 2016 AForm 4 → | Aug 18, 5:50 pm EDT | Anne VanlentDirector | 16,000 | — | — | 16,000 | — | |
| Jul 7, 2016 AForm 4 → | Jul 11, 4:59 pm EDT | Jeffrey D. ChulaySee Remarks | 35,000 | — | — | 35,000 | — | |
| Jul 7, 2016 AForm 4 → | Jul 11, 4:58 pm EDT | Mark S ShearmanChief Scientific Officer | 50,000 | — | — | 50,000 | — | |
| Jul 7, 2016 AForm 4 → | Jul 11, 4:58 pm EDT | Stephen W PotterSee Remarks | 50,000 | — | — | 50,000 | — | |
| Jul 7, 2016 AForm 4 → | Jul 11, 4:57 pm EDT | Lawrence E BullockChief Financial Officer | 35,000 | — | — | 35,000 | — | |
| Jul 7, 2016 AForm 4 → | Jul 11, 4:56 pm EDT | Susan B. WasherSee Remarks, Director | 80,000 | — | — | 80,000 | — | |
| May 25, 2016 MForm 4 → | May 26, 7:03 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 2,000 | — | — | 2,028 | — | |
| May 11, 2016 MForm 4 → | May 26, 7:00 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 4,000 | — | — | 4,028 | — | late |
| Nov 19, 2015 AForm 4 → | Dec 4, 4:35 pm EST | Arnold L OronskyDirector | 6,200 | — | — | 6,200 | — | late |
| Nov 19, 2015 AForm 4 → | Dec 4, 4:35 pm EST | James RosenDirector | 6,200 | — | — | 6,200 | — | late |
| Nov 19, 2015 AForm 4 → | Dec 4, 4:34 pm EST | Scott KoenigDirector | 6,200 | — | — | 6,200 | — | late |
| Nov 19, 2015 AForm 4 → | Dec 4, 4:34 pm EST | Bruce PeacockDirector | 6,200 | — | — | 6,200 | — | late |
| Nov 19, 2015 AForm 4 → | Dec 4, 4:33 pm EST | Ivana MagovcevicDirector | 6,200 | — | — | 6,200 | — | late |
| Nov 19, 2015 AForm 4 → | Dec 4, 4:31 pm EST | Edward HurwitzDirector | 6,200 | — | — | 6,200 | — | late |
| Jul 21, 2015 AForm 4/A → | Aug 24, 4:06 pm EDT | Mark S ShearmanChief Scientific Officer | 51,000 | — | — | 51,000 | — | |
| Jul 21, 2015 AForm 4/A → | Aug 24, 4:05 pm EDT | Stephen W PotterSee Remarks | 51,000 | — | — | 51,000 | — | |
| Jul 21, 2015 AForm 4 → | Jul 23, 8:08 pm EDT | Jeffrey D. ChulaySee Remarks | 71,000 | — | — | 71,000 | — | |
| Jul 21, 2015 AForm 4 → | Jul 23, 8:06 pm EDT | Susan B. WasherPresident and CEO, Director | 80,000 | — | — | 80,000 | — | |
| Jul 21, 2015 AForm 4 → | Jul 23, 8:05 pm EDT | Mark S ShearmanChief Scientific Officer | 51,000 | — | — | 51,000 | — | amended |
| Jul 21, 2015 AForm 4 → | Jul 23, 8:05 pm EDT | Lawrence E BullockChief Financial Officer | 37,000 | — | — | 37,000 | — | |
| Jul 21, 2015 AForm 4 → | Jul 23, 8:05 pm EDT | Stephen W PotterSee Remarks | 51,000 | — | — | 51,000 | — | amended |
| Jun 1, 2015 AForm 4 → | Jun 2, 4:07 pm EDT | Mark S ShearmanChief Scientific Officer | 110,000 | — | — | 110,000 | — | |
| Mar 18, 2015 AForm 4 → | Mar 20, 5:11 pm EDT | Bruce PeacockDirector | 9,375 | — | — | 9,375 | — | |
| Jan 29, 2015 AForm 4 → | Feb 2, 5:02 pm EST | Stephen W PotterVP and Chief Business Officer | 131,049 | — | — | 131,049 | — | |
| Jan 23, 2015 MForm 4 → | Jan 26, 6:04 pm EST | Daniel L MenichellaV.P. & Chief Business Officer | 1,996 | — | — | 115,972 | — | |
| Nov 13, 2014 MForm 5 → | Aug 14, 2015, 4:05 pm EDT | Jeffrey D. ChulayVP and Chief Medical Officer | 7,277 | — | — | 30,511 | — | |
| Jul 11, 2014 AForm 4 → | Sep 28, 2015, 6:36 pm EDT | Ivana MagovcevicDirector | 9,375 | — | — | 9,375 | — | late |